Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review

多靶点调控机制及天然产物治疗失眠的临床评价:综述

阅读:1

Abstract

BACKGROUND: Insomnia, a prevalent sleep disorder, adversely impacts patients' quality of life and imposes significant burdens on both physical and mental health. While conventional insomnia therapies remain widely utilized, they exhibit persistent safety limitations, including risks of dependence and cognitive impairment. Natural products have garnered increasing scientific interest owing to their favorable safety profiles and demonstrated therapeutic efficacy. This comprehensive review critically examines contemporary advances in understanding the mechanistic actions of natural products against insomnia and their supporting clinical evidence, with the objective of synthesizing their pharmacological mechanisms, clinical effectiveness, and safety evaluations. METHODS: This systematic review retrieved relevant literature through comprehensive searches of four core biomedical databases (ScienceDirect, PubMed, Ovid MEDLINE, and Web of Science), encompassing peer-reviewed articles published between January 2020 and August 2025. The retrieval strategy focuses on identifying original research papers concerning the treatment of insomnia using purified natural products and traditional Chinese medicine compound formulations. RESULTS: Natural products demonstrate significant therapeutic efficacy against insomnia through multi-target mechanisms, including: modulation of GABAergic neurotransmission, regulation of orexinergic signaling pathways, attenuation of inflammatory responses and oxidative stress, restructuring gut microbiota composition, and normalization of core circadian regulators (notably CLOCK/BMAL1 complexes). Critically, clinical evidence confirms these natural products treatment outcomes with favorable safety profiles in insomnia management. CONCLUSION: This review critically evaluates contemporary advances in botanical therapeutics for insomnia management, synthesizing evidence to inform evidence-based clinical translation and facilitate the development of novel pharmacotherapeutic strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。